Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Price:
0.1601 USD
Updated:
Apr 30, 2024
Sonoma Pharmaceuticals Inc
Research & Development
|
Sonoma Pharmaceuticals Inc
Research & Development Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
Research & Development
-$1.7m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
0%
|
CAGR 10-Years
5%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Research & Development
-$15.1B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-6%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Research & Development
-$9.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-9%
|
|
|
Pfizer Inc
NYSE:PFE
|
Research & Development
-$10.6B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-5%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Research & Development
-$29.8B
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
-15%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Research & Development
-$9.3B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-5%
|
See Also
What is Sonoma Pharmaceuticals Inc's Research & Development?
Research & Development
-1.7m
USD
-1.7m
USD
Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Research & Development amounts to -1.7m USD.
What is Sonoma Pharmaceuticals Inc's Research & Development growth rate?
Research & Development CAGR 10Y
5%
5%
Over the last year, the Research & Development growth was -16 610%. The average annual Research & Development growth rates for Sonoma Pharmaceuticals Inc have been -23% over the past three years , and 5% over the past ten years .
You don't have any saved screeners yet
